Ovalbumin-specific T-cell receptor

The **ovalbumin-specific T-cell receptor** refers not to a single molecule, but to a class of experimentally engineered or selected T-cell receptors (TCRs) that specifically recognize peptides derived from the chicken ovalbumin (OVA) protein when presented by defined major histocompatibility complex (MHC) molecules. The best-known examples are the OT-I (MHC class I-restricted, recognizes OVA257-264, selects for CD8+ cytotoxic T cells) and OT-II (MHC class II-restricted, recognizes OVA323-339, selects for CD4+ helper T cells) TCR transgenic mice, which are widely used in immunological research for controlled antigen-specific T cell response modeling[2][6]. These TCRs are not found naturally in humans and are not considered direct therapeutic targets, but are critical laboratory tools for studying mechanisms of antigen-specific T-cell activation, signaling, selection, and immunological memory[1][2][6]. Due to their experimental, artificial origin and their role as a research tool—not a natural human or therapeutic target—the entry is considered "incorrect" for the context of drug targeting databases. These receptors are not linked to established or investigated drug interactions, mechanisms of action, biomarkers, or safety concerns applicable in clinical or translational settings[2][6][8]. Additional context: - **Alias usage**: "OT-I" and "OT-II" refer to specific mouse lines or their TCRs[2][6]. - The ovalbumin-specific TCRs are widely cited in immunological literature for dissecting TCR signaling and peptide-MHC recognition in preclinical mouse models[1][2][6]. - These TCRs have enabled discoveries about the quantitative and qualitative aspects of T cell activation and selection, but they are not relevant as direct clinical therapeutic targets.

Other names

OT-I TCROT-II TCROVA-specific TCROVA TCROvalbumin TCR